Neuroophthalmological symptoms of pituitary adenomas with supraparasellar extension
Journal Title: Офтальмологический журнал - Year 2019, Vol 0, Issue 5
Abstract
Background: Pituitary adenomas (PA) are benign neoplasms that arise from adenohypophysis; they are most common skull base tumors, and account for 12% to15% of all intracranial tumors. In PA with supraparasellar extension, a tumor grows upward, causing chiasmal and lateral cavernous sinus compression. Because prolonged compression of the optic nerve/chiasm complex results in the development of primary descending ONA in 31% to 72% of patients, leading to blindness in 3.5% to 16% of patients, the issue is worthy of attention. Purpose: To investigate neuro-ophthalmological symptoms in pituitary adenomas with a supraparasellar extension before and after treatment. Materials and Methods: This retrospective study included the records of 107 patients who received treatment for pituitary adenomas with a supraparasellar extension at the Romodanov Institute during 2017 to 2018. The main group included 49 patients (98 eyes) who had visual impairments and/or visual field deficits. Patients underwent clinical and neurological, eye and otoneurological examination (including neuroimaging studies) before and after treatment. Results: Visual impairments with the development of markedly asymmetric chiasmal syndrome were most common in the clinical picture, with a severe visual acuity loss (25.5% of eyes) and significant sensitivity loss (39.8% of eyes) in the more affected eye, mild or moderate visual acuity loss and visual field loss in the less affected eye, and development of primary descending optic nerve atrophy in 36 (73.5%) patients. After treatment, visual acuity restored or improved in 57 (58.2%) eyes, and arithmetic mean of the sensitivity loss, the mean defect (MD), improved in 46 (46.9%) eyes (these improvements were significant, p < 0.05). Conclusion: Pituitary adenomas with supraparasellar extension were characterized by the development of visual and oculomotor impairments, which evidenced the presence of various directions of tumor expansion. Visual impairments with the development of markedly asymmetric chiasmal syndrome were most common in the clinical picture. Mean BCVA improved from 0.51±0.04 at baseline to 0.66±0.03 after treatment, and mean overall visual field sensitivity loss improved from 12.11 ± 0.69 dB at baseline to 8.6 ± 0.7 dB after treatment (both improvements were significant, p < 0.05).
Authors and Affiliations
K. Iegorova, M. Guk, O. Guk, L. Danevych, D. Tsiurupa
Physiological properties of fluid circulation in the crystalline lens in animals with regard to a phase of accommodation
The work was supported by Russian Fund of Fundamental Studies (Project No 16-06-00439). Background. Traditional ideas about the fluid circulation in the lens assume its movement through the lens capsul...
Prevention of macular edema and secondary degeneration of the macula and posterior pole in anterior uveitis
Background. Endogenous uveitis is an inflammatory disease of the uvea, making up to 30% in the ophthalmology overall structure according to various authors. Uveitis is among current socially important issues in ophthalmo...
Comparison of morphometric changes in the chorioretinal complex after anti-VEGF treatment in patients with pathologic myopia versus those with neovascular age-related macular degeneration
Purpose: To compare morphometric changes in the chorioretinal complex after anti-vascular endothelial growth factor (anti-VEGF) treatment in patients with pathologic myopia (PM)-related choroidal neovascularization (CNV)...
Prevalence of ocular diseases in patients with pulmonary tuberculosis and HIV infection
Background: Given the high prevalence and rate of disability from ocular pathologies, it is clinically and socially important to determine their prevalence in patients with tuberculosis and HIV infection. Purpose: To det...
Value of static automated perimetry in assessing visual impairments in patients with pituitary adenoma with suprasellar extension
Background: Pituitary adenoma (PA) is a neoplasm that develops from anterior pituitary cells and accounts for 20-25% of all intracranial extracerebral tumors. In a functioning PA, a specific clinical syndrome develops, a...